Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference
Mont-Saint-Guibert, Belgium – November 21, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Piper Sandler 35th Annual Healthcare Conference, which takes place November 28 – 30, 2023 in New York.
- Mont-Saint-Guibert, Belgium – November 21, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Piper Sandler 35th Annual Healthcare Conference, which takes place November 28 – 30, 2023 in New York.
- Olivier Taelman, Nyxoah’s Chief Executive Officer, will be participating in a Fireside Chat on Wednesday, November 29, 2023, at 2:30pm ET.
- A webcast of the presentation will be available on the Events section of Nyxoah’s Investor Relations website.
- Nyxoah’s Investor Presentation can be accessed on the Shareholder Information section of the Company’s Investor Relations page.